Position in PFE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$862,401
-$145,362 QoQ
Shares Held
35,814
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,416
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
This page
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,401 | 35,814 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,007,763 | 35,889 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $894,881 | 35,939 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,010,587 | 39,662 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,059,288 | 43,700 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,216,320 | 48,000 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,362,793 | 51,368 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $1,505,285 | 52,014 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,275,412 | 45,583 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,395,325 | 50,282 | Shares | Sole | 2024-05-22 | |
| 2023-09-30 | $1,973,051 | 59,483 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,180,479 | 59,446 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,446,653 | 59,967 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $3,423,754 | 66,818 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,952,180 | 67,463 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,582,122 | 68,322 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $3,454,819 | 66,734 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,982,686 | 67,446 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,845,369 | 66,156 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,502,558 | 63,906 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,329,009 | 64,284 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,290,097 | 62,214 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,143,205 | 112,894 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,963,015 | 60,031 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,927,715 | 59,060 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||